How diet affects brain health and Alzheimer's disease in diverse populations
Official title: Dietary factors, neuroinflammation, plasma neurodegenerative biomarkers and Alzheimer’s disease in diverse cohorts
Funded at Rush University Medical Center · NIH-10985586 · Data updated 2026-11-12
This study is looking at how eating healthy foods might help keep our brains healthy and lower the risk of Alzheimer's disease, especially in different groups of people, and it involves sharing your eating habits and checking your brain health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rush University Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | September 15, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2024 |
| Award (this year) | $787,390 |
| NIH project number | 1R01AG085483-01A1 |
| Project ID | NIH-10985586 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include older adults from diverse backgrounds who are concerned about cognitive decline or have a family history of Alzheimer's disease.
✕Less likely to help
Patients with advanced Alzheimer's disease or those who are unable to provide dietary information may not benefit from this research.
What this research studies
This research investigates the impact of healthy diets on brain health and the risk of Alzheimer's disease (AD) in various populations. It aims to understand how dietary factors, such as antioxidants and essential fatty acids, influence neuroinflammation and the presence of biomarkers associated with AD. By studying these relationships, the research seeks to uncover the mechanisms that link diet to cognitive decline and AD pathology, particularly in underrepresented groups. Participants may provide dietary information and undergo assessments to evaluate their cognitive health and related biomarkers.
Why it matters
Potential benefit: If successful, this research could lead to dietary recommendations that help reduce the risk of Alzheimer's disease and improve cognitive health in diverse populations.
How similar studies have gone: Previous research has shown promising results in understanding the relationship between diet and cognitive health, but this study focuses on diverse populations, making it a novel approach.
Where this research is happening
-
Rush University Medical Center
Chicago, United States Active
Researchers
- Principal investigator: Agarwal, Puja — Rush University Medical Center
- Study coordinator: Agarwal, Puja
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.